Resumen
Dopamine receptors have been described in T-cells, however their signalling pathways coupled remain unknown. Since cAMP and ERKs play key roles regulating T-cell physiology, we aim to determine whether cAMP and ERK1/2-phosphorylation are modulated by dopamine receptor 3 (D3R) and D5R, and how this modulation affects CD4+ T-cell activation and differentiation. Our pharmacologic and genetic evidence shows that D3R-stimulation reduced cAMP levels and ERK2-phosphorylation, consequently increasing CD4+ T-cell activation and Th1-differentiation, respectively. Moreover, D5R expression reinforced TCR-triggered ERK1/2-phosphorylation and T-cell activation. In conclusion, these findings demonstrate how D3R and D5R modulate key signalling pathways affecting CD4+ T-cell activation and Th1-differentiation.
Idioma original | Inglés |
---|---|
Páginas (desde-hasta) | 18-29 |
Número de páginas | 12 |
Publicación | Journal of Neuroimmunology |
Volumen | 284 |
DOI | |
Estado | Publicada - 2015 |
Nota bibliográfica
Publisher Copyright:© 2015 Elsevier B.V.
Áreas temáticas de ASJC Scopus
- Inmulogía y alergología
- Inmunología
- Neurología
- Neurología clínica